JP2018500351A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018500351A5 JP2018500351A5 JP2017533901A JP2017533901A JP2018500351A5 JP 2018500351 A5 JP2018500351 A5 JP 2018500351A5 JP 2017533901 A JP2017533901 A JP 2017533901A JP 2017533901 A JP2017533901 A JP 2017533901A JP 2018500351 A5 JP2018500351 A5 JP 2018500351A5
- Authority
- JP
- Japan
- Prior art keywords
- trans
- phenyl
- amino
- cyclohexyl
- phenylpyridin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- TZDFCQQFICPDHL-UHFFFAOYSA-N CCC(C(C)C1CCC(CC(Nc2nnc(-c3ccc(C(C4)(CC4=[F])N)cc3)c(-c3ccccc3)c2)=O)CC1)=O Chemical compound CCC(C(C)C1CCC(CC(Nc2nnc(-c3ccc(C(C4)(CC4=[F])N)cc3)c(-c3ccccc3)c2)=O)CC1)=O TZDFCQQFICPDHL-UHFFFAOYSA-N 0.000 description 1
- FDFNITYLYNNGMR-VCCPSZSWSA-N CCC(CC(CC)=O)[C@H]1CC[C@H](CC(Nc2ncc(-c3ccc([C@](C4)(C[C@@]4(C)O)N)cc3)c(-c3ccccc3)c2)=O)CC1 Chemical compound CCC(CC(CC)=O)[C@H]1CC[C@H](CC(Nc2ncc(-c3ccc([C@](C4)(C[C@@]4(C)O)N)cc3)c(-c3ccccc3)c2)=O)CC1 FDFNITYLYNNGMR-VCCPSZSWSA-N 0.000 description 1
- 0 C[C@](C1)(C[C@@]1(c(c(F)c1)ccc1-c1cnc(CCNC(C[C@](CC2)CC[C@@]2N(C)C(C)=*)=O)cc1-c1ccccc1)N)O Chemical compound C[C@](C1)(C[C@@]1(c(c(F)c1)ccc1-c1cnc(CCNC(C[C@](CC2)CC[C@@]2N(C)C(C)=*)=O)cc1-c1ccccc1)N)O 0.000 description 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201423087 | 2014-12-23 | ||
| GB1423087.4 | 2014-12-23 | ||
| GB1508787.7 | 2015-05-22 | ||
| GBGB1508787.7A GB201508787D0 (en) | 2014-12-23 | 2015-05-22 | Pharmaceutically active compounds |
| GB1519919.3 | 2015-11-11 | ||
| GBGB1519919.3A GB201519919D0 (en) | 2015-11-11 | 2015-11-11 | Pharmaceutically active compounds |
| PCT/EP2015/081168 WO2016102672A2 (en) | 2014-12-23 | 2015-12-23 | Pharmaceutically active compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020139060A Division JP2020189880A (ja) | 2014-12-23 | 2020-08-20 | 医薬的活性化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018500351A JP2018500351A (ja) | 2018-01-11 |
| JP2018500351A5 true JP2018500351A5 (enExample) | 2019-01-10 |
| JP6787899B2 JP6787899B2 (ja) | 2020-11-18 |
Family
ID=56151566
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017533901A Expired - Fee Related JP6787899B2 (ja) | 2014-12-23 | 2015-12-23 | 医薬的活性化合物 |
| JP2020139060A Pending JP2020189880A (ja) | 2014-12-23 | 2020-08-20 | 医薬的活性化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020139060A Pending JP2020189880A (ja) | 2014-12-23 | 2020-08-20 | 医薬的活性化合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US10336702B2 (enExample) |
| EP (1) | EP3240784A2 (enExample) |
| JP (2) | JP6787899B2 (enExample) |
| KR (1) | KR20170115042A (enExample) |
| CN (1) | CN107207472B (enExample) |
| AU (1) | AU2015370911B2 (enExample) |
| CA (1) | CA2971763A1 (enExample) |
| WO (1) | WO2016102672A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017538678A (ja) * | 2014-11-05 | 2017-12-28 | フレクサス・バイオサイエンシーズ・インコーポレイテッドＦｌｅｘｕｓ Ｂｉｏｓｃｉｅｎｃｅｓ， Ｉｎｃ． | 免疫調節剤 |
| AU2015370911B2 (en) * | 2014-12-23 | 2020-07-09 | Bergenbio Asa | Inhibitors of Akt kinase |
| TWI794171B (zh) | 2016-05-11 | 2023-03-01 | 美商滬亞生物國際有限公司 | Ｈｄａｃ抑制劑與ｐｄ-ｌ１抑制劑之組合治療 |
| TWI808055B (zh) | 2016-05-11 | 2023-07-11 | 美商滬亞生物國際有限公司 | Hdac 抑制劑與 pd-1 抑制劑之組合治療 |
| JP2020506885A (ja) | 2017-01-13 | 2020-03-05 | 江蘇恒瑞医薬股▲ふん▼有限公司 | １，２，４−トリアジン−３−アミン誘導体、その製造方法、および医薬におけるその使用 |
| CN111989313A (zh) * | 2018-02-15 | 2020-11-24 | 杭州阿诺生物医药科技有限公司 | A2a和/或a2b受体拮抗剂 |
| JP2021523379A (ja) | 2018-05-14 | 2021-09-02 | ベルゲンビオ アーエスアー | 血清バイオマーカー |
| CN111171065A (zh) * | 2020-02-26 | 2020-05-19 | 上海博黑生物科技有限公司 | 一种(4-(1-((叔丁氧基羰基)氨基)环丙基)苯基)硼酸酯的合成方法 |
| CN115916196A (zh) * | 2020-05-05 | 2023-04-04 | 纽威伦特公司 | 杂芳族大环醚化学治疗剂 |
| EP4146205A4 (en) | 2020-05-05 | 2024-05-29 | Nuvalent, Inc. | HETEROAROMATIC MACROCYCLIC ETHERS AS CHEMOTHERAPEUTIC AGENTS |
| KR102853833B1 (ko) * | 2020-12-21 | 2025-09-02 | 동우 화인켐 주식회사 | 양자점, 양자점 분산체, 광변환 경화성 조성물, 컬러필터, 광변환 적층기재 및 화상표시장치 |
| WO2025066935A1 (en) * | 2023-09-28 | 2025-04-03 | Hepaitech (Beijing) Biopharma Technology Co., Ltd. | Compounds, compositions and methods thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6486199B1 (en) * | 2001-06-21 | 2002-11-26 | Medicines For Malaria Venture Mmv International Centre Cointrin | Spiro and dispiro 1,2,4-trioxolane antimalarials |
| EP1720855A4 (en) | 2004-03-02 | 2008-12-17 | Smithkline Beecham Corp | HEMMER OF ACT ACTIVITY |
| DE602005026509D1 (de) * | 2004-04-09 | 2011-04-07 | Merck Sharp & Dohme | Hemmer der akt aktivität |
| ES2270715B1 (es) * | 2005-07-29 | 2008-04-01 | Laboratorios Almirall S.A. | Nuevos derivados de pirazina. |
| GB0922589D0 (en) * | 2009-12-23 | 2010-02-10 | Almac Discovery Ltd | Pharmaceutical compounds |
| PT2928898T (pt) * | 2012-12-07 | 2021-07-05 | Venatorx Pharmaceuticals Inc | Inibidores de beta-lactamase |
| AU2015370911B2 (en) * | 2014-12-23 | 2020-07-09 | Bergenbio Asa | Inhibitors of Akt kinase |
-
2015
- 2015-12-23 AU AU2015370911A patent/AU2015370911B2/en not_active Ceased
- 2015-12-23 CA CA2971763A patent/CA2971763A1/en active Pending
- 2015-12-23 CN CN201580075417.7A patent/CN107207472B/zh not_active Expired - Fee Related
- 2015-12-23 JP JP2017533901A patent/JP6787899B2/ja not_active Expired - Fee Related
- 2015-12-23 EP EP15823511.9A patent/EP3240784A2/en not_active Withdrawn
- 2015-12-23 WO PCT/EP2015/081168 patent/WO2016102672A2/en not_active Ceased
- 2015-12-23 US US15/533,048 patent/US10336702B2/en active Active
- 2015-12-23 KR KR1020177019939A patent/KR20170115042A/ko not_active Ceased
-
2019
- 2019-05-15 US US16/412,590 patent/US10766861B2/en not_active Expired - Fee Related
-
2020
- 2020-07-14 US US16/928,142 patent/US20210070708A1/en not_active Abandoned
- 2020-08-20 JP JP2020139060A patent/JP2020189880A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018500351A5 (enExample) | ||
| JP2015502335A5 (enExample) | ||
| JP6417419B2 (ja) | 免疫調節剤として有用な化合物 | |
| RU2454405C2 (ru) | Производные 3-пиридинкарбоксамида и 2-пиразинкарбоксамида в качестве агентов, повышающих уровень лвп-холестерина | |
| JP2022185107A5 (enExample) | ||
| RU2017145650A (ru) | Ингибиторы тирозинкиназы брутона | |
| JP2005526723A5 (enExample) | ||
| JP2018531981A5 (enExample) | ||
| CA2903288A1 (en) | N-acyl-n'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities | |
| JP2018529650A5 (enExample) | ||
| CN1428145A (zh) | 用作速激肽nk3受体拮抗剂的喹啉衍生物 | |
| JP2011520896A5 (enExample) | ||
| JP2019518766A5 (enExample) | ||
| EP2477976A1 (en) | Quinazolinone derivatives as viral polymerase inhibitors | |
| JP2020527175A5 (enExample) | ||
| AR089134A1 (es) | Arilos y heteroarilos biciclicos inhibidores de los canales de sodio | |
| JP2017533968A5 (enExample) | ||
| JP2014507455A5 (enExample) | ||
| JP2014506599A5 (enExample) | ||
| WO2014145029A2 (en) | N-acyl-n'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities | |
| JP2017525757A5 (enExample) | ||
| JP2020506946A5 (enExample) | ||
| JP2014508128A5 (enExample) | ||
| JP2021502387A5 (enExample) | ||
| JP2009529059A5 (enExample) |